Seismic Therapeutic
Minasri Borah has extensive experience in various research and laboratory settings, primarily focused on oncology, diabetes, heart diseases, Parkinson's disease, and CRISPR/CAS9-based Genome Editing. With a background in veterinary science, Minasri has held roles ranging from Veterinary Officer to Senior Research Specialist, showcasing a versatile skill set in both animal and laboratory research. Minasri's expertise includes conducting experiments, maintaining cell lines, dosing animals, and generating drug-resistant cell lines. Currently serving as a Vivarium Manager and Senior Associate Scientist II at Seismic Therapeutic, Minasri continues to make significant contributions to the field of research.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.